Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean A Fletcher

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Cancer|December 22, 2017
Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standardSebastian Berg, Sean A Fletcher, Alexander P Cole, et al.
Urologic Oncology|December 24, 2021
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancerSean A Fletcher, Trinity J Bivalacqua, Otis W Brawley, et al.
The Journal of Urology|August 19, 2022
Lost in Transparency: The 21st Century Cures Act ("Open Notes") and Prostate Cancer CareAndrew T Gabrielson, Una Choi, Sean A Fletcher, et al.
The Lancet. Oncology|February 8, 2018
Adoption of robotic surgery: driven by market competition or a desire to improve patient care?Sean A Fletcher, Alexander P Cole, Sebastian Berg, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|October 22, 2024
Cytoreductive Nephrectomy Following Immunotherapy for Metastatic Renal Cell Carcinoma and IVC Tumor Thrombus Arising from a Horseshoe KidneySean A Fletcher, Rachel Schendzielos, Michael E Rezaee, et al.
Urologic Oncology|February 14, 2024
Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equalMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
The Journal of Urology|October 2, 2024
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?Yasin Bhanji, Mufaddal K Mamawala, Sean A Fletcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Barriers to Quality End-of-Life Care for Patients With Blood CancersOreofe O Odejide, Angel M Cronin, Nolan B Condron, et al.
The Prostate|March 13, 2024
Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI eraSean A Fletcher, Mufaddal M Mamawala, Albert E Holler, et al.
The Journal of Urology|June 24, 2026
The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active SurveillanceJack A Campbell, David Ali, Michael E Rezaee, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Cancer|December 22, 2017
Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standardSebastian Berg, Sean A Fletcher, Alexander P Cole, et al.
Urologic Oncology|December 24, 2021
Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancerSean A Fletcher, Trinity J Bivalacqua, Otis W Brawley, et al.
The Journal of Urology|August 19, 2022
Lost in Transparency: The 21st Century Cures Act ("Open Notes") and Prostate Cancer CareAndrew T Gabrielson, Una Choi, Sean A Fletcher, et al.
The Lancet. Oncology|February 8, 2018
Adoption of robotic surgery: driven by market competition or a desire to improve patient care?Sean A Fletcher, Alexander P Cole, Sebastian Berg, et al.
Kidney Cancer Journal : Official Journal of the Kidney Cancer Association|October 22, 2024
Cytoreductive Nephrectomy Following Immunotherapy for Metastatic Renal Cell Carcinoma and IVC Tumor Thrombus Arising from a Horseshoe KidneySean A Fletcher, Rachel Schendzielos, Michael E Rezaee, et al.
Urologic Oncology|February 14, 2024
Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equalMichael E Rezaee, Maximilian Pallauf, Sean A Fletcher, et al.
The Journal of Urology|October 2, 2024
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?Yasin Bhanji, Mufaddal K Mamawala, Sean A Fletcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Barriers to Quality End-of-Life Care for Patients With Blood CancersOreofe O Odejide, Angel M Cronin, Nolan B Condron, et al.
The Prostate|March 13, 2024
Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI eraSean A Fletcher, Mufaddal M Mamawala, Albert E Holler, et al.
The Journal of Urology|June 24, 2026
The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients with Prostate Cancer on Active SurveillanceJack A Campbell, David Ali, Michael E Rezaee, et al.
Pageof 6